Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 6

Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome?

Pages
1021–1028
Publication Date
2014-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To determine the levels of adipokines (leptin, adiponectin, resistin, and visfatin) and the indices of insulin sensitivity/resistance, and to examine the relationship among them in patients with metabolic syndrome (MetS).
📊
Key Findings & Data:Materials and methods: The study groups included 45 subjects with MetS (31 women/14 men), and 45 sex-and age-matched non-MetS healthy volunteers (31 women/14 men).
💡
Conclusion & Impact:Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Adiponectin · insulin resistance · metabolic syndrome

Abstract

To determine the levels of adipokines (leptin, adiponectin, resistin, and visfatin) and the indices of insulin sensitivity/resistance, and to examine the relationship among them in patients with metabolic syndrome (MetS). Materials and methods: The study groups included 45 subjects with MetS (31 women/14 men), and 45 sex-and age-matched non-MetS healthy volunteers (31 women/14 men). The levels of adipokines were determined by enzyme-linked immunosorbent assay. Results: The levels of leptin and visfatin were significantly higher in the MetS than in the non-MetS subjects (P < 0.01). There was no difference in adiponectin levels in subjects with and without MetS (P = 0.052). Similarly, resistin did not show any statistically significant difference. A statistically significant positive correlation of leptin with insulin levels was observed, while negative correlations of visfatin levels with age, and resistin levels with the ratio of adiponectin to leptin, were found in the MetS (P < 0.05). The combination of adipokines, insulin resistance-sensitivity parameters, and MetS criteria parameters gave more significant differences than a single parameter. Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.

Özet

To determine the levels of adipokines (leptin, adiponectin, resistin, and visfatin) and the indices of insulin sensitivity/resistance, and to examine the relationship among them in patients with metabolic syndrome (MetS). Materials and methods: The study groups included 45 subjects with MetS (31 women/14 men), and 45 sex-and age-matched non-MetS healthy volunteers (31 women/14 men). The levels of adipokines were determined by enzyme-linked immunosorbent assay. Results: The levels of leptin and visfatin were significantly higher in the MetS than in the non-MetS subjects (P < 0.01). There was no difference in adiponectin levels in subjects with and without MetS (P = 0.052). Similarly, resistin did not show any statistically significant difference. A statistically significant positive correlation of leptin with insulin levels was observed, while negative correlations of visfatin levels with age, and resistin levels with the ratio of adiponectin to leptin, were found in the MetS (P < 0.05). The combination of adipokines, insulin resistance-sensitivity parameters, and MetS criteria parameters gave more significant differences than a single parameter. Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.

🔖

Cite This Article

KURAL, B., DEĞER, O., EREM, C., YÜCESAN, F. B. (2014). Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome?. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 6, 1021–1028. https://ajindex.com/articles/215200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Garg MK, Dutta MK, Mahalle N. Adipokines (adiponectin and plasminogen activator inhibitor-1) in metabolic syndrome. Indian J Endocrinol Metab 2012; 16: 116–123
  2. Kotani K, Sakane N. Leptin:adiponectin ratio and metabolic syndrome in the general Japanese population. Korean J Lab Med 2011; 31: 162–166
  3. Silva FM, de Almeida JC, Feoli AM. Effect of diet on adiponectin levels in blood. Nutr Rev 2011; 69: 599–612
  4. Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation, and immunity. Endocr Regul 2010; 44: 25–36
  5. Yadav A, Jyoti P, Jain SK, Bhattacharjee J. Correlation of adiponectin and leptin with insulin resistance: a pilot study in healthy north Indian population. Ind J Clin Biochem 2011; 26: 193–196
  6. La Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004; 82: 4–11
  7. Jamaluddin MS, Weakley SM, Yao Q, Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012; 165: 622–632
  8. Kamińska A, Kopczyńska E, Bronisz A, Zmudzińska M, Bieliński M, Borkowska A, Tyrakowski T, Junik R. An evaluation of visfatin levels in obese subjects. Endokrynol Pol 2010; 61: 169–173
  9. Wang P, Vanhoutte PM, Miao CY. Visfatin and cardio-cerebrovascular disease. J Cardiovasc Pharmacol 2012; 59: 1–9
  10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497
  11. Vanizor Kural B, Değer O, Erem C, Balaban Yücesan F, Barlak Y, Turan İ, Aliyazıcıoğlu R. Sequence variant in the LPIN1 gene in patients with metabolic syndrome. Turk J Biochem 2013; 38: 280–285
  12. Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, Ersöz HO, Telatar M. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res 2004; 12: 1117–1127
  13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
  14. Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Ueda S, Funahashi T, Matsuzawa Y. A novel index of insulin resistance determined from the homeostasis